Corporate Information And Statement Of Ifrs Compliance [Abstract]

Ascelia Pharma - Filing #678716

Concept	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	Ascelia	—
Legal form of entity	—	AB	—
Country of incorporation	—	Sverige.	—
Address of entity's registered office	—	Bolagets	—
Description of nature of entity's operations and principal activities	—	utvecklar	—
Statement of IFRS compliance [text block]	—	Koncernredovisningen	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade payables	1 525 SEK	—	15 881 SEK
Disclosure of assets and liabilities with significant risk of material adjustment [text block]	—	Aktierelaterade	—